Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

2001183 citationsJournal Articlehybrid Open Access

Authors

Stanislas Pol · Inserm

Bertrand Nalpas · Hôpital Necker-Enfants Malades

Françoise Driss

Marie-Louise Michel · Inserm

Pierre Tiollais · Inserm

Jacques Denis · Centre Hospitalier Laennec

Christian Bréchot · Hôpital Necker-Enfants Malades

Abstract

This controlled study offers direct evidence that the HBV vaccine may decrease HBV replication in chronic hepatitis B patients. It also emphasizes the need for reinforced immunization strategies as well as combination therapies.

Topics & Keywords

Hepatitis B Virus Studies Hepatitis C virus research Immunotherapy and Immune Responses

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Hepatology

Volume 34, Issue 6, pp. 917-921

DOI: 10.1016/s0168-8278(01)00028-9

Field-Weighted Citation Impact: 8.22